CLENZIDERM THERAPEUTIC

Product NDC
62032-113
11-digit product format
620320113
Labeler code
62032
Product ID
62032-113_93b5a3fe-6f00-49bc-be4e-cc4847be1eb4
Type
HUMAN OTC DRUG
Nonproprietary name
BENZOYL PEROXIDE
Dosage form
LOTION
Route
TOPICAL
Labeler
OMP, INC.
Application
part333D
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2007-07-01
Marketing end
0000-00-00
Substance
BENZOYL PEROXIDE
Active strength
50 mg/mL
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct62032-113IInactivated by FDA2026-10-05
excluded packagepackage62032-11362032-113-65IInactivated by FDA2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage62032-113-65d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage62032-113-65f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage62032-113-652ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage62032-113-65a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage62032-113-65cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage62032-113-65cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage62032-113-65302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage62032-113-65ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage62032-113-650efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage62032-113-65ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage62032-113-65367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage62032-113-65557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-28excluded productproduct8af77b9d5b6f…d9bbb34c5368…
2024-05-28 21:12 UTC · source 2024-05-28excluded packagepackage62032-113-658af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14excluded productproduct834df4deac94…adcc014656a3…
2024-05-15 03:39 UTC · source 2024-05-14excluded packagepackage62032-113-65834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-08excluded productproduct1332a3947898…d4bfe170f9cd…
2024-03-11 06:39 UTC · source 2024-03-08excluded packagepackage62032-113-651332a3947898…d4bfe170f9cd…
2022-08-30 03:57 UTC · source 2022-08-29excluded productproductfb8cb913e6d1…eb8c232b6be0…
2022-08-30 03:57 UTC · source 2022-08-29excluded packagepackage62032-113-65fb8cb913e6d1…eb8c232b6be0…
2022-04-09 23:13 UTC · source 2022-04-08excluded productproduct86f5da6cb304…a595104c45d7…
2022-04-09 23:13 UTC · source 2022-04-08excluded packagepackage62032-113-6586f5da6cb304…a595104c45d7…
2022-04-04 05:40 UTC · source 2022-04-01excluded productproductbd6a592717d7…303034d00443…
2022-04-04 05:40 UTC · source 2022-04-01excluded packagepackage62032-113-65bd6a592717d7…303034d00443…
2021-12-27 23:28 UTC · source 2021-12-27excluded productproduct8dfbde2a14a4…c9ff85d89658…
2021-12-27 23:28 UTC · source 2021-12-27excluded packagepackage62032-113-658dfbde2a14a4…c9ff85d89658…
2020-12-18 03:04 UTC · source 2020-12-17excluded productproducte2bbac7714bc…27bdfed8d636…
2020-12-18 03:04 UTC · source 2020-12-17excluded packagepackage62032-113-65e2bbac7714bc…27bdfed8d636…
2020-06-10 20:45 UTC · source 2020-06-10excluded productproduct9bebd1f3094a…5416666fcb17…
2020-06-10 20:45 UTC · source 2020-06-10excluded packagepackage62032-113-659bebd1f3094a…5416666fcb17…
2019-12-08 06:16 UTC · source 2019-12-05excluded productproduct110d247fa046…a55b01930146…
2019-12-08 06:16 UTC · source 2019-12-05excluded packagepackage62032-113-65110d247fa046…a55b01930146…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a46239a7-5963-4008-8cbb-6b9000f497ebProduct name120250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19Product name320250317
d9d61457-6a5a-41fc-b418-e5479a2904b7Product name220230303
32012d5c-25ac-49c7-9d4c-1313177fff7cProduct name120230112
13e7e7e3-e885-4c79-af6d-dad1aedbb06eProduct name120220128
4a7d44fe-774d-404b-aad0-8a90fe78375aProduct name420211025
3f45980c-c196-47e5-0e5e-48b7c57327c5Product name520200428
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27bProduct name320200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992Product name420190619
ad75fcfd-a339-42a1-9c60-43ba2c654cfaProduct name120170810

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
62032-113-652019-11-13C16284748780-197449f38-b82e-f6ea-e053-dbdaa90aa703OBAGI ® CLENZIderm M.D.™ Therapeutic Lotion

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62032-113-65CLENZIDERM NORMAL TO DRY SKINACNE THERAPEUTIC SYSTEM47 mL in 1 BOTTLE, PLASTICLOTION47 mL50 mg in 1mL2
62032-113-65CLENZIDERM THERAPEUTIC47 mL in 1 BOTTLE, PLASTICLOTION471
62032-113-65CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM47 mL in 1 BOTTLE, PLASTICLOTION47 mL50 mg in 1mL1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
BENZOYL PEROXIDEACTIVE INGREDIENTW9WZN9A0GMCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
BENZOYL PEROXIDEACTIVE INGREDIENTW9WZN9A0GMCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
BENZOYL PEROXIDEACTIVE INGREDIENTW9WZN9A0GMCLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1
GLYCERINACTIVE INGREDIENTPDC6A3C0OXCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
SALICYLIC ACIDACTIVE INGREDIENTO414PZ4LPZCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
BENZOYL PEROXIDEACTIVE MOIETYW9WZN9A0GMCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
BENZOYL PEROXIDEACTIVE MOIETYW9WZN9A0GMCLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1
BENZOYL PEROXIDEACTIVE MOIETYW9WZN9A0GMCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
GLYCERINACTIVE MOIETYPDC6A3C0OXCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
SALICYLIC ACIDACTIVE MOIETYO414PZ4LPZCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
3-((L-MENTHYL)OXY)PROPANE-1,2-DIOLINACTIVE INGREDIENTKD6TZ2QICHCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
ALCOHOLINACTIVE INGREDIENT3K9958V90MCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
ALLANTOININACTIVE INGREDIENT344S277G0ZCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W7CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBHCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
BENZYL BENZOATEINACTIVE INGREDIENTN863NB338GCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
BENZYL BENZOATEINACTIVE INGREDIENTN863NB338GCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
BENZYL BENZOATEINACTIVE INGREDIENTN863NB338GCLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171KCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171KCLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1
BUTYLATED HYDROXYTOLUENEINACTIVE INGREDIENT1P9D0Z171KCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
BUTYLPARABENINACTIVE INGREDIENT3QPI1U3FV8CLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
CARBOMER INTERPOLYMER TYPE A (55000 MPA.S)INACTIVE INGREDIENT59TL3WG5COCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
CETYL HYDROXYETHYLCELLULOSE (350000 MW)INACTIVE INGREDIENTT7SWE4S2TTCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
COCAMIDOPROPYL BETAINEINACTIVE INGREDIENT5OCF3O11KXCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
CYCLOMETHICONE 5INACTIVE INGREDIENT0THT5PCI0RCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
DICAPRYLYL ETHERINACTIVE INGREDIENT77JZM5516ZCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
DICAPRYLYL ETHERINACTIVE INGREDIENT77JZM5516ZCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
DICAPRYLYL ETHERINACTIVE INGREDIENT77JZM5516ZCLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1
DIETHYLENE GLYCOL MONOETHYL ETHERINACTIVE INGREDIENTA1A1I8X02BCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1OCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
DIMETHYL ISOSORBIDEINACTIVE INGREDIENTSA6A6V432SCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
DIMETHYL ISOSORBIDEINACTIVE INGREDIENTSA6A6V432SCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
DIMETHYL ISOSORBIDEINACTIVE INGREDIENTSA6A6V432SCLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86KCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86KCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86KCLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1
ETHYLPARABENINACTIVE INGREDIENT14255EXE39CLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
EXT. D&C VIOLET NO. 2INACTIVE INGREDIENTG5UX3K0728CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
ISOBUTYLPARABENINACTIVE INGREDIENT0QQJ25X58GCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
LAURYL PEG/PPG-18/18 METHICONEINACTIVE INGREDIENTZJ5S27D9NXCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
MENTHOLINACTIVE INGREDIENTL7T10EIP3ACLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
MENTHYL LACTATE, (-)-INACTIVE INGREDIENT2BF9E65L7ICLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9TCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3TCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3TCLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3TCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
POLYSORBATE 60INACTIVE INGREDIENTCAL22UVI4MCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
POLYSORBATE 60INACTIVE INGREDIENTCAL22UVI4MCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
POLYSORBATE 60INACTIVE INGREDIENTCAL22UVI4MCLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3CLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3CLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OHCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
SODIUM LAURETH SULFATEINACTIVE INGREDIENTBPV390UAP0CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
SODIUM LAURYL SULFATEINACTIVE INGREDIENT368GB5141JCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
SQUALANEINACTIVE INGREDIENTGW89575KF9CLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1
SQUALANEINACTIVE INGREDIENTGW89575KF9CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
SQUALANEINACTIVE INGREDIENTGW89575KF9CLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
TROLAMINEINACTIVE INGREDIENT9O3K93S3TKCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
WATERINACTIVE INGREDIENT059QF0KO0RCLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1
WATERINACTIVE INGREDIENT059QF0KO0RCLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1
WATERINACTIVE INGREDIENT059QF0KO0RCLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62032-113CLENZIDERM NORMAL TO DRY SKIN ACNE THERAPEUTIC SYSTEM (GLYCERIN AND BENZOYL PEROXIDE) KIT [OMP, INC.]2Legacy NDC20171219_95cf7f25-0416-4b77-ad7c-f382ebd470bb.zip
62032-113CLENZIDERM NORMAL TO OILY SKIN ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OMP, INC.]1Legacy NDC20120518_934ec314-1ab7-45ee-a2fe-8bff3ff981b6.zip
62032-113CLENZIDERM THERAPEUTIC (BENZOYL PEROXIDE) LOTION [OMP, INC.]1Legacy NDC, 1 package rows20120106_1904602f-0979-4002-a408-ddcd07cde429.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
106309benzoyl peroxide 5 % Topical LotionPSN95cf7f25-0416-4b77-ad7c-f382ebd470bb2
1236624Clenziderm Lotion 5 % Topical LotionPSN95cf7f25-0416-4b77-ad7c-f382ebd470bb2
1236624benzoyl peroxide 50 MG/ML Topical Lotion [Clenziderm Lotion]SBD95cf7f25-0416-4b77-ad7c-f382ebd470bb2
106309benzoyl peroxide 50 MG/ML Topical LotionSCD95cf7f25-0416-4b77-ad7c-f382ebd470bb2
106309benzoyl peroxide 5 % Topical LotionSY95cf7f25-0416-4b77-ad7c-f382ebd470bb2
1236624Clenziderm Lotion 5 % Topical LotionSY95cf7f25-0416-4b77-ad7c-f382ebd470bb2
1236624Clenziderm Lotion 50 MG/ML Topical LotionSY95cf7f25-0416-4b77-ad7c-f382ebd470bb2
106309benzoyl peroxide 5 % Topical LotionPSN1904602f-0979-4002-a408-ddcd07cde4291
106309benzoyl peroxide 5 % Topical LotionPSN934ec314-1ab7-45ee-a2fe-8bff3ff981b61
1236624Clenziderm Lotion 5 % Topical LotionPSN1904602f-0979-4002-a408-ddcd07cde4291
1236624Clenziderm Lotion 5 % Topical LotionPSN934ec314-1ab7-45ee-a2fe-8bff3ff981b61
1235205CLENZIderm M.D. 2 % Medicated Liquid SoapPSN934ec314-1ab7-45ee-a2fe-8bff3ff981b61
1235208CLENZIderm M.D. 2 % Pore Therapy Topical SolutionPSN934ec314-1ab7-45ee-a2fe-8bff3ff981b61
562600salicylic acid 2 % Medicated Liquid SoapPSN934ec314-1ab7-45ee-a2fe-8bff3ff981b61
251577salicylic acid 2 % Topical SolutionPSN934ec314-1ab7-45ee-a2fe-8bff3ff981b61
1236624benzoyl peroxide 50 MG/ML Topical Lotion [Clenziderm Lotion]SBD1904602f-0979-4002-a408-ddcd07cde4291
1236624benzoyl peroxide 50 MG/ML Topical Lotion [Clenziderm Lotion]SBD934ec314-1ab7-45ee-a2fe-8bff3ff981b61
1235205salicylic acid 20 MG/ML Medicated Liquid Soap [Clenziderm]SBD934ec314-1ab7-45ee-a2fe-8bff3ff981b61
1235208salicylic acid 20 MG/ML Topical Solution [Clenziderm]SBD934ec314-1ab7-45ee-a2fe-8bff3ff981b61
106309benzoyl peroxide 50 MG/ML Topical LotionSCD1904602f-0979-4002-a408-ddcd07cde4291
106309benzoyl peroxide 50 MG/ML Topical LotionSCD934ec314-1ab7-45ee-a2fe-8bff3ff981b61
562600salicylic acid 20 MG/ML Medicated Liquid SoapSCD934ec314-1ab7-45ee-a2fe-8bff3ff981b61
251577salicylic acid 20 MG/ML Topical SolutionSCD934ec314-1ab7-45ee-a2fe-8bff3ff981b61
106309benzoyl peroxide 5 % Topical LotionSY1904602f-0979-4002-a408-ddcd07cde4291
106309benzoyl peroxide 5 % Topical LotionSY934ec314-1ab7-45ee-a2fe-8bff3ff981b61
1235205Clenziderm 20 MG/ML Medicated Liquid SoapSY934ec314-1ab7-45ee-a2fe-8bff3ff981b61
1235208Clenziderm 20 MG/ML Topical SolutionSY934ec314-1ab7-45ee-a2fe-8bff3ff981b61
1236624Clenziderm Lotion 5 % Topical LotionSY934ec314-1ab7-45ee-a2fe-8bff3ff981b61
1236624Clenziderm Lotion 5 % Topical LotionSY1904602f-0979-4002-a408-ddcd07cde4291
1236624Clenziderm Lotion 50 MG/ML Topical LotionSY934ec314-1ab7-45ee-a2fe-8bff3ff981b61
1236624Clenziderm Lotion 50 MG/ML Topical LotionSY1904602f-0979-4002-a408-ddcd07cde4291
1235205Clenziderm M.D. 2 % Daily Care CleanserSY934ec314-1ab7-45ee-a2fe-8bff3ff981b61
1235208Clenziderm M.D. 2 % Pore TherapySY934ec314-1ab7-45ee-a2fe-8bff3ff981b61
562600salicylic acid 2 % Facial Cleanser TonerSY934ec314-1ab7-45ee-a2fe-8bff3ff981b61
562600salicylic acid 2 % Facial ScrubSY934ec314-1ab7-45ee-a2fe-8bff3ff981b61
562600salicylic acid 2 % Medicated Liquid SoapSY934ec314-1ab7-45ee-a2fe-8bff3ff981b61
251577salicylic acid 2 % Topical SolutionSY934ec314-1ab7-45ee-a2fe-8bff3ff981b61

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsStatus
62032-113-656203201136547 mL in 1 BOTTLE, PLASTIC47 mlHistorical